ERBB2 and breast cancer: Trastuzumab, an inhibitory antibody to ErbB2 (human epidermal growth factor receptor 2 or HER2/neu) used in the treatment of breast cancer, can induce cardiac dysfunction and HF, suggesting an important role for ErbB2 in the heart.